Manuscript
High p95HER2/HER2 ratio associated with poor outcome in Trastuzumab-treated HER2-positive metastatic breast cancer NCCTG N0337 and NCCTG 98-32-52 (Alliance)
March 1, 2018
所在地を検索
営業時間、予約なし診療およびご予約。